{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:45:10Z","timestamp":1790516710609,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.beha.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,5,25]],"date-time":"2013-05-25T09:45:21Z","timestamp":1369475121000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Epstein\u2013Barr virus-associated natural killer\/T-cell lymphomas"],"prefix":"10.1016","volume":"26","author":[{"given":"Naoko","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2013.04.002_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008"},{"key":"10.1016\/j.beha.2013.04.002_bib2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK)-cell neoplasms: aggressive NK-cell leukemia and extranodal NK-cell lymphoma, nasal-type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2013.04.002_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2008.02997.x","article-title":"Nodal T\/NK-cell lymphoma of nasal type: a clinicopathological study of six cases","volume":"52","author":"Takahashi","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2013.04.002_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1440-1827.1997.tb04433.x","article-title":"Clinicopathologic study of nasal T\/NK-cell lymphoma among the Japanese","volume":"47","author":"Nakamura","year":"1997","journal-title":"Pathol Int"},{"key":"10.1016\/j.beha.2013.04.002_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.1997.1462962.x","article-title":"CD56\u00fe NK lymphomas: clinicopathological features and prognosis","volume":"97","author":"Kwong","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.002_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<477::AID-CNCR16>3.0.CO;2-U","article-title":"Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy","volume":"80","author":"Logsdon","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.002_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.002_bib8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.002_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3960\/jslrt.45.51","article-title":"Leukemia and lymphoma of natural killer cells","volume":"45","author":"Suzuki","year":"2005","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.beha.2013.04.002_bib10","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"278","article-title":"EBV-positive T-cell lymphoproliferative disorders of childhood","author":"Quintanilla-Martinez","year":"2008"},{"key":"10.1016\/j.beha.2013.04.002_bib11","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"306","article-title":"Peripheral T-cell lymphoma, not otherwise specified","author":"Pileri","year":"2008"},{"key":"10.1016\/j.beha.2013.04.002_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2013.04.002_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Kato","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2013.04.002_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","article-title":"Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage","volume":"31","author":"Ohshima","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2013.04.002_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the workshop on nasal and related extranodal angiocentric T\/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2013.04.002_bib16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.002_bib17","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","article-title":"CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas","volume":"87","author":"Emile","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.002_bib18","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","article-title":"Expression of adult and fetal natural killer cell markers in sinonasal lymphomas","volume":"83","author":"Suzumiya","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.002_bib19","first-page":"25","article-title":"Discordant reaction of Leu4 and rabbit anti-human CD3 epsilon in sinonasal \u2018T\u2019-cell lymphoma","volume":"59","author":"Yamaguchi","year":"1993","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2013.04.002_bib20","first-page":"699","article-title":"Expression of perforin in nasal lymphoma","volume":"149","author":"Mori","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2013.04.002_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","article-title":"Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma","volume":"100","author":"Li","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.002_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0046-8177(95)90277-5","article-title":"Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections","volume":"26","author":"Chan","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beha.2013.04.002_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hed.20015","article-title":"Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis","volume":"26","author":"Kim","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.beha.2013.04.002_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2013.04.002_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3960\/jslrt.41.93","article-title":"Treatment outcome of nasal NK-cell lymphoma: a report of 12 consecutively-diagnosed cases and a review of the literature","volume":"41","author":"Yamaguchi","year":"2001","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.beha.2013.04.002_bib26","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.002_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","article-title":"P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, P SC83","volume":"93","author":"Egashira","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.002_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","article-title":"Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment","volume":"18","author":"Kim","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.002_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2013.04.002_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2402148","article-title":"Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx","volume":"15","author":"Ribrag","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.002_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1016\/j.beha.2013.04.002_bib32","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan Clinical Oncology Group study JCOG0211","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.002_bib33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer (NK)-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.002_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02982090","article-title":"l-asparaginase induced durable remission of relapsed nasal NK\/T-cell lymphoma after autologous peripheral blood stem cell transplantation","volume":"74","author":"Nagafuji","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2013.04.002_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02983802","article-title":"l-asparaginase-based induction therapy for advanced extranodal NK\/T-cell lymphoma","volume":"78","author":"Obama","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2013.04.002_bib36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/1042819031000067873","article-title":"Successful treatment with Erwinia L-asparaginase for recurrent natural killer\/T cell lymphoma","volume":"44","author":"Matsumoto","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2013.04.002_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","article-title":"L-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma","volume":"78","author":"Yong","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2013.04.002_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2004.04863.x","article-title":"The best way to use asparaginase in childhood acute lymphatic leukaemia \u2013 still to be defined?","volume":"125","author":"Pinheiro","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.002_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.04.002_bib40","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly-diagnosed stage IV, relapsed or refractory extranodal NK\/T-cell lymphoma, nasal type: the NK-cell Tumor Study Group (NKTSG) study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.002_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","article-title":"Hematopoietic stem cell transplantation for natural killer cell lineage neoplasms","volume":"37","author":"Suzuki","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2013.04.002_bib42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","article-title":"Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms","volume":"130","author":"Murashige","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.002_bib43","doi-asserted-by":"crossref","first-page":"503a","DOI":"10.1182\/blood.V118.21.503.503","article-title":"Comparison of autologous and allogeneic hematopoietic stem cell transplantation for extranodal NK\/T cell lymphoma, nasal-type: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T04:40:17Z","timestamp":1595824817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1521692613000030"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.002","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein\u2013Barr virus-associated natural killer\/T-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}